Cargando…

An evaluation of Wb123 antibody elisa in individuals treated with ivermectin and albendazole, and implementation challenges in Africa

The development of antibody testing for the diagnosis of lymphatic filariasis (LF) is intended to enhance the monitoring and evaluation activities of the Global Program for the Elimination of LF. This is due to the fact that antibody tests are expected to be the most sensitive at detecting exposure...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Souza, Dziedzom Komi, Owusu, Irene Offei, Otchere, Joseph, Adimazoya, Michelle, Frempong, Kwadwo, Ahorlu, Collins Stephen, Boakye, Daniel Adjei, Wilson, Michael David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The African Field Epidemiology Network 2017
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5554654/ https://www.ncbi.nlm.nih.gov/pubmed/28819487 http://dx.doi.org/10.11604/pamj.2017.27.65.11004

Ejemplares similares

Community-based trial of annual versus biannual single-dose ivermectin plus albendazole against Wuchereria bancrofti infection in human and mosquito populations: study protocol for a cluster randomised controlled trial
por: de Souza, Dziedzom K., et al.
Publicado: (2017)

Transmission indices and microfilariae prevalence in human population prior to mass drug administration with ivermectin and albendazole in the Gomoa District of Ghana
por: Aboagye-Antwi, Fred, et al.
Publicado: (2015)

Community perspectives on persistent transmission of lymphatic filariasis in three hotspot districts in Ghana after 15 rounds of mass drug administration: a qualitative assessment
por: Ahorlu, Collins S. K., et al.
Publicado: (2018)

Review of MDA registers for Lymphatic Filariasis: Findings, and potential uses in addressing the endgame elimination challenges
por: de Souza, Dziedzom K., et al.
Publicado: (2020)

Potential factors influencing lymphatic filariasis transmission in “hotspot” and “control” areas in Ghana: the importance of vectors
por: Pi-Bansa, Sellase, et al.
Publicado: (2019)

Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection
por: Henriquez‐Camacho, Cesar, et al.
Publicado: (2016)

Efficacy and reinfection with soil-transmitted helminths 18-weeks post-treatment with albendazole-ivermectin, albendazole-mebendazole, albendazole-oxantel pamoate and mebendazole
por: Speich, Benjamin, et al.
Publicado: (2016)

Assessing Lymphatic Filariasis Data Quality in Endemic Communities in Ghana, Using the Neglected Tropical Diseases Data Quality Assessment Tool for Preventive Chemotherapy
por: de Souza, Dziedzom K., et al.
Publicado: (2016)

Does Increasing Treatment Frequency Address Suboptimal Responses to Ivermectin for the Control and Elimination of River Blindness?
por: Frempong, Kwadwo K., et al.
Publicado: (2016)

Ivermectin treatment in humans for reducing malaria transmission
por: Souza, Dziedzom K, et al.
Publicado: (2021)

Detection of Gastrointestinal Nematode Populations Resistant to Albendazole and Ivermectin in Sheep
por: Mondragón-Ancelmo, Jaime, et al.
Publicado: (2019)

Identification of Wb123 as an Early and Specific Marker of Wuchereria bancrofti Infection
por: Kubofcik, Joseph, et al.
Publicado: (2012)

Efficacy of High-Dose Albendazole with Ivermectin for Treating Imported Loiasis, Italy
por: Gobbi, Federico, et al.
Publicado: (2019)

Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa
por: Fischer, Peter U., et al.
Publicado: (2017)

Triple Co-Administration of Ivermectin, Albendazole and Praziquantel in Zanzibar: A Safety Study
por: Mohammed, Khalfan A., et al.
Publicado: (2008)

Assessment of the usefulness of anti-Wb123 antibody for post-elimination surveillance of lymphatic filariasis
por: Dorkenoo, Ameyo Monique, et al.
Publicado: (2021)

A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis
por: Opoku, Nicholas O., et al.
Publicado: (2023)

Comparison of Repeated Doses of Ivermectin Versus Ivermectin Plus Albendazole for the Treatment of Onchocerciasis: A Randomized, Open-label, Clinical Trial
por: Batsa Debrah, Linda, et al.
Publicado: (2020)

Recurrent Hemorrhagic Pericardial Effusion and Tamponade due to Filariasis Successfully Treated with Ivermectin and Albendazole
por: Sinha, Santosh Kumar, et al.
Publicado: (2015)

Effectiveness Evaluation of Levamisole, Albendazole, Ivermectin, and Vernonia amygdalina in West African Dwarf Goats
por: Adediran, Oyeduntan A., et al.
Publicado: (2015)

Efficacy of Novel Formulations of Ivermectin and Albendazole in Parasitic Infections of Sheep in the Altai Mountains of Russia
por: Marchenko, Victor Alexeevich, et al.
Publicado: (2021)

Accelerating the Uptake of WHO Recommendations for Mass Drug Administration Using Ivermectin, Diethylcarbamazine, and Albendazole
por: King, Jonathan D., et al.
Publicado: (2022)

Efficacy and safety of moxidectin and albendazole compared to ivermectin and albendazole co-administration in adolescents infected with Trichuris trichiura: a randomized controlled trial protocol
por: Welsche, Sophie, et al.
Publicado: (2021)

Different gut microbial communities correlate with efficacy of albendazole-ivermectin against soil-transmitted helminthiases
por: Schneeberger, Pierre H. H., et al.
Publicado: (2022)

Synthesis and Clinical Examination of Novel Formulations of Ivermectin, Albendazole and Niclosamide for the Treatment of Equine Gastrointestinal Helminthoses
por: Marchenko, Victor Alexeevich, et al.
Publicado: (2023)

An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia
por: Supali, Taniawati, et al.
Publicado: (2021)

Treatment of W. bancrofti (Wb) in HIV/Wb Coinfections in South India
por: Talaat, Kawsar R., et al.
Publicado: (2015)

Lymphatic Filariasis Control in Tanzania: Effect of Repeated Mass Drug Administration with Ivermectin and Albendazole on Infection and Transmission
por: Simonsen, Paul E., et al.
Publicado: (2010)

Prevalence of Lymphatic Filariasis and Treatment Effectiveness of Albendazole/ Ivermectin in Individuals with HIV Co-infection in Southwest-Tanzania
por: Kroidl, Inge, et al.
Publicado: (2016)

Analysis of the population-level impact of co-administering ivermectin with albendazole or mebendazole for the control and elimination of Trichuris trichiura
por: Turner, Hugo C., et al.
Publicado: (2016)

Impact of Annual versus Semiannual Mass Drug Administration with Ivermectin and Albendazole on Helminth Infections in Southeastern Liberia
por: Eneanya, Obiora A., et al.
Publicado: (2022)

Investigation of the Efficacy of Pyrantel Pamoate, Mebendazole, Albendazole, and Ivermectin against Baylisascaris schroederi in Captive Giant Pandas
por: Lu, Yaxian, et al.
Publicado: (2022)

An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India
por: Jambulingam, Purushothaman, et al.
Publicado: (2021)

Low Microfilaremia Levels in Three Districts in Coastal Ghana with at Least 16 Years of Mass Drug Administration and Persistent Transmission of Lymphatic Filariasis
por: de Souza, Dziedzom K., et al.
Publicado: (2018)

Long-term outcomes of ivermectin-albendazole versus albendazole alone against soil-transmitted helminths: Results from randomized controlled trials in Lao PDR and Pemba Island, Tanzania
por: Keller, Ladina, et al.
Publicado: (2021)

Mass drug administration of ivermectin, diethylcarbamazine, plus albendazole compared with diethylcarbamazine plus albendazole for reduction of lymphatic filariasis endemicity in Papua New Guinea: a cluster-randomised trial
por: Laman, Moses, et al.
Publicado: (2022)

Efficacy and Safety of Single and Double Doses of Ivermectin versus 7-Day High Dose Albendazole for Chronic Strongyloidiasis
por: Suputtamongkol, Yupin, et al.
Publicado: (2011)

Lymphatic filariasis control in Tanzania: effect of six rounds of mass drug administration with ivermectin and albendazole on infection and transmission
por: Simonsen, Paul E, et al.
Publicado: (2013)

Correction: Prevalence of Lymphatic Filariasis and Treatment Effectiveness of Albendazole/ Ivermectin in Individuals with HIV Co-infection in Southwest-Tanzania
por: Kroidl, Inge, et al.
Publicado: (2016)

Pharmacokinetics, feasibility and safety of co-administering azithromycin, albendazole, and ivermectin during mass drug administration: A review
por: McPherson, Scott, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ouh9las5fo5rk9d7cloqmtg7fo